Home
>
National Drug Code (NDC)
>
BC
BC - 0135-0500-02 - (aspirin and caffeine)
Drug Information of BC
| Product NDC: | 0135-0500 |
| Proprietary Name: | BC |
| Non Proprietary Name: | aspirin and caffeine |
| Active Ingredient(s): | 845; 65 mg/1; mg/1 & nbsp; aspirin and caffeine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of BC
| Product NDC: | 0135-0500 |
| Labeler Name: | GlaxoSmithKline Consumer Healthcare LP |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part343 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20100608 |
Package Information of BC
| Package NDC: | 0135-0500-02 |
| Package Description: | 2 POWDER in 1 PACKAGE (0135-0500-02) |
NDC Information of BC
| NDC Code | 0135-0500-02 |
| Proprietary Name | BC |
| Package Description | 2 POWDER in 1 PACKAGE (0135-0500-02) |
| Product NDC | 0135-0500 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | aspirin and caffeine |
| Dosage Form Name | POWDER |
| Route Name | ORAL |
| Start Marketing Date | 20100608 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | GlaxoSmithKline Consumer Healthcare LP |
| Substance Name | ASPIRIN; CAFFEINE |
| Strength Number | 845; 65 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |
